114 related articles for article (PubMed ID: 8931458)
1. 2'-deoxyadenosine induces apoptosis in rat chromaffin cells.
Wakade AR; Guo X; Palmer KC; Kulkarni JS; Przywara DA; Wakade TD
J Neurochem; 1996 Dec; 67(6):2273-81. PubMed ID: 8931458
[TBL] [Abstract][Full Text] [Related]
2. Deoxynucleoside induces neuronal apoptosis independent of neurotrophic factors.
Wakade AR; Przywara DA; Palmer KC; Kulkarni JS; Wakade TD
J Biol Chem; 1995 Jul; 270(30):17986-92. PubMed ID: 7629106
[TBL] [Abstract][Full Text] [Related]
3. Nucleoside transporter subtype expression: effects on potency of adenosine kinase inhibitors.
Sinclair CJ; Powell AE; Xiong W; LaRivière CG; Baldwin SA; Cass CE; Young JD; Parkinson FE
Br J Pharmacol; 2001 Nov; 134(5):1037-44. PubMed ID: 11682452
[TBL] [Abstract][Full Text] [Related]
4. Characterization of inhibitor-sensitive and -resistant adenosine transporters in cultured human fetal astrocytes.
Gu JG; Nath A; Geiger JD
J Neurochem; 1996 Sep; 67(3):972-7. PubMed ID: 8752102
[TBL] [Abstract][Full Text] [Related]
5. Adenosine-induced apoptosis in chick embryonic sympathetic neurons: a new physiological role for adenosine.
Wakade TD; Palmer KC; McCauley R; Przywara DA; Wakade AR
J Physiol; 1995 Oct; 488 ( Pt 1)(Pt 1):123-38. PubMed ID: 8568648
[TBL] [Abstract][Full Text] [Related]
6. Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosine.
Dawicki DD; Agarwal KC; Parks RE
Biochem Pharmacol; 1985 Nov; 34(22):3965-72. PubMed ID: 4062970
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of similarities and differences in neurotoxicities caused by adenosine and 2'-deoxyadenosine in sympathetic neurons.
Kulkarni JS; Wakade AR
J Neurochem; 1996 Aug; 67(2):778-86. PubMed ID: 8764607
[TBL] [Abstract][Full Text] [Related]
8. Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation.
Hershfield MS; Kredich NM
Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4292-6. PubMed ID: 6254019
[TBL] [Abstract][Full Text] [Related]
9. Activation of apoptosis in early mouse embryos by 2'-deoxyadenosine exposure.
Gao X; Blackburn MR; Knudsen TB
Teratology; 1994 Jan; 49(1):1-12. PubMed ID: 8171392
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the abilities of nitrobenzylthioinosine, dilazep, and dipyridamole to protect human hematopoietic cells from 7-deazaadenosine (tubercidin).
Cass CE; King KM; Montaño JT; Janowska-Wieczorek A
Cancer Res; 1992 Nov; 52(21):5879-86. PubMed ID: 1394215
[TBL] [Abstract][Full Text] [Related]
11. Adenosine kinase inhibitors augment release of adenosine from spinal cord slices.
Golembiowska K; White TD; Sawynok J
Eur J Pharmacol; 1996 Jun; 307(2):157-62. PubMed ID: 8832217
[TBL] [Abstract][Full Text] [Related]
12. Adenosine and deoxyadenosine induces apoptosis in oestrogen receptor-positive and -negative human breast cancer cells via the intrinsic pathway.
Hashemi M; Karami-Tehrani F; Ghavami S; Maddika S; Los M
Cell Prolif; 2005 Oct; 38(5):269-85. PubMed ID: 16202036
[TBL] [Abstract][Full Text] [Related]
13. Co-administration of adenosine kinase and deaminase inhibitors produces supra-additive potentiation of N-methyl-D-aspartate-evoked adenosine formation in cortex.
Hebb MO; White TD
Eur J Pharmacol; 1998 Mar; 344(2-3):121-5. PubMed ID: 9600645
[TBL] [Abstract][Full Text] [Related]
14. Adenosine metabolism in human whole blood. Effects of nucleoside transport inhibitors and phosphate concentration.
Dawicki DD; Agarwal KC; Parks RE
Biochem Pharmacol; 1988 Feb; 37(4):621-6. PubMed ID: 3342099
[TBL] [Abstract][Full Text] [Related]
15. 2'-Deoxyadenosine causes cell death in embryonic chicken sympathetic ganglia and brain.
Zhao Z; Crossland WJ; Kulkarni JS; Wakade TD; Wakade AR
Cell Tissue Res; 1999 May; 296(2):281-91. PubMed ID: 10382272
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
Bontemps F; Van den Berghe G
Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
[TBL] [Abstract][Full Text] [Related]
17. Protection by various deoxynucleosides against deoxyadenosine-induced DNA damage in adenosine deaminase-inactivated lymphocytes.
Shimoyama RK; Seto S; Mori C
Mol Genet Metab; 1999 Dec; 68(4):455-60. PubMed ID: 10607474
[TBL] [Abstract][Full Text] [Related]
18. Adenine/ribose supply increases adenosine production and protects ATP pool in adenosine kinase-inhibited cardiac cells.
Smolenski RT; Kalsi KK; Zych M; Kochan Z; Yacoub MH
J Mol Cell Cardiol; 1998 Mar; 30(3):673-83. PubMed ID: 9515042
[TBL] [Abstract][Full Text] [Related]
19. Increased adenosine deaminase (ADA) activity and a shift from ADA-dependent to ADA-independent phases during T-cell activation: a paradox.
Veit BC; Fishman M; Look T
J Natl Cancer Inst; 1984 May; 72(5):1151-9. PubMed ID: 6609265
[TBL] [Abstract][Full Text] [Related]
20. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
Kurtzberg J; Hershfield MS
Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
